Nano-quantum sensors-based imaging and sensing for target-based drug discovery and development

被引:1
|
作者
Shimada, Taisuke [1 ]
Ueda, Yasuyuki [2 ]
Takemaru, Hikari [2 ,3 ]
Baba, Yoshinobu [1 ,2 ,4 ]
Yukawa, Hiroshi [2 ,4 ,5 ,6 ]
机构
[1] Nagoya Univ, Grad Sch Engn, Dept Biomol Engn, Furo Cho,Chikusa Ku, Nagoya 4648603, Japan
[2] Natl Inst Quantum Sci & Technol QST, Inst Quantum Life Sci, Anagawa 4-9-1,Inage Ku, Chiba 2638555, Japan
[3] Chiba Univ, Grad Sch Sci & Engn, Div Adv Sci & Engn, Inage Ku, 1-33 Yayoicho,Inage Ku, Chiba 2638522, Japan
[4] Nagoya Univ, Inst Nanolife Syst, Inst Innovat Future Soc, Furo Cho,Chikusa Ku, Nagoya 4648603, Japan
[5] Nagoya Univ, Inst Adv Res, Adv Analyt & Diagnost Imaging Ctr AADIC, Med Engn Unit MEU,B3 Unit, Tsurumai Cho 65,Showa Ku, Nagoya 4668550, Japan
[6] Nagoya Univ, Dev Quantum Nano Canc Photoimmunotherapy Clin Appl, Tsurumai 65,Showa Ku, Nagoya 4668550, Japan
关键词
Nano -quantum sensor; Quantum dot; Fluorescent nanodiamond; Surface modification; Target specificity; Imaging; Sensing; Theranostics; PHOTOCHEMICAL MODIFICATION; FLUORESCENT NANODIAMONDS; STEM-CELLS; DOTS; SURFACE; FUNCTIONALIZATION; SEMICONDUCTOR; LIGANDS; NANOPARTICLES; NANOCRYSTALS;
D O I
10.1016/j.trac.2023.117496
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Biological imaging and sensing are vital for understanding the biochemical and biological processes related to drug discovery and development. Nano-quantum sensors such as quantum dots and fluorescent nanodiamonds are luminescent nanoparticle sensors with excellent optical properties originating from quantum effects, and these sensors are promising for long-term imaging and physicochemical sensing with high spatiotemporal resolution. However, owing to the requirements of biological compatibility and target specificity for such sensor applications, modifying the sensor surfaces is essential. Moreover, owing to the demand for imaging- and sensing-assisted therapies (theranostics), a combination of nano-quantum sensors and therapeutic agents has been developed via surface modifications. We herein outline advanced surface modifications of nano-quantum sensors and their applications in in vitro and in vivo imaging, sensing, and therapy for target-based drug discovery and development.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Methodological aspects of current problems in target-based anticancer drug development
    Yamanaka T.
    Okamoto T.
    Ichinose Y.
    Oda S.
    Maehara Y.
    International Journal of Clinical Oncology, 2006, 11 (3) : 167 - 175
  • [32] Development of Target-Based Antineoplastic Agents
    Walter M. Stadler
    Mark J. Ratain
    Investigational New Drugs, 2000, 18 : 7 - 16
  • [33] Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening
    Kumar, Vikrant
    Lakshman, Puneeth Kumar Chunchagatta
    Prasad, Thazhe Kootteri
    Manjunath, Kavyashree
    Bairy, Sneha
    Vasu, Akshaya S.
    Ganavi, B.
    Jasti, Subbarao
    Kamariah, Neelagandan
    HELIYON, 2024, 10 (01)
  • [34] Quantum dot approaches for target-based drug screening and multiplexed active biosensing
    Kovtun, Oleg
    Arzeta-Ferrer, Xochitl
    Rosenthal, Sandra J.
    NANOSCALE, 2013, 5 (24) : 12072 - 12081
  • [35] Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
    Kaminski, Tim
    Gunnarsson, Anders
    Geschwindner, Stefan
    ACS SENSORS, 2017, 2 (01): : 10 - 15
  • [36] Weak links: Advancing target-based drug discovery by identifying the most vulnerable targets
    Bosch, Barbara
    Dejesus, Michael A.
    Schnappinger, Dirk
    Rock, Jeremy M.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2024, 1535 (01) : 10 - 19
  • [37] Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
    Swinney, D. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (04) : 299 - 301
  • [38] Target-based discovery of a broad-spectrum flukicide
    Sprague, Daniel J.
    Park, Sang-Kyu
    Gramberg, Svenja
    Bauer, Lisa
    Rohr, Claudia M.
    Chulkov, Evgeny G.
    Smith, Emery
    Scampavia, Louis
    Spicer, Timothy P.
    Haeberlein, Simone
    Marchant, Jonathan S.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2024, 31 (09) : 1386 - 1393
  • [39] Target-based approaches for the discovery of new antimycobactrial drugs
    Borsari, Chiara
    Ferrari, Stefania
    Venturelli, Alberto
    Costi, Maria Paola
    DRUG DISCOVERY TODAY, 2017, 22 (03) : 576 - 584
  • [40] Designing innovative therapies for neuropathic pain: pros and cons of target-based drug discovery
    Inglese, J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 : S6 - S9